Regadenoson Hydrate is a selective adenosine A2A receptor agonist and coronary vasodilator used primarily in pharmacologic stress testing for myocardial perfusion imaging. By inducing transient hyperemia,… Read more
Regadenoson Hydrate is a selective adenosine A2A receptor agonist and coronary vasodilator used primarily in pharmacologic stress testing for myocardial perfusion imaging. By inducing transient hyperemia, this agent allows clinicians to assess blood flow and diagnose coronary artery disease in patients unable to exercise adequately. The pharmaceutical category of Regadenoson Hydrate includes essential reference standards, degradation products, and process-related impurities required for rigorous analytical testing and quality control. Analytical laboratories utilize these high-purity reference materials for method validation, such as developing HPLC procedures, and for comprehensive impurity profiling to meet regulatory standards. Furthermore, stable isotope labelled compounds are available to serve as internal standards in mass spectrometry-based assays, ensuring precise quantification and supporting stability studies throughout the drug development process. These compounds are critical for maintaining compliance with international quality guidelines and verifying the safety and efficacy of the final pharmaceutical substance.